ARTICLE | Company News
Oxford GlycoSciences, Glaxo Wellcome deal
December 4, 2000 8:00 AM UTC
OGS will use its glycosylation-derived proteomics platform to discover biomarkers associated with diseases of interest to GLXO, which will have rights to therapeutic applications. OGS is eligible for ...